2015年至2022年培养阳性结核病的耐药性特征
Zhenzhen Wang1,2, Liyang Xu2,3, Tengfei Guo1
1The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Frontiers in public health
|June 9, 2025
概括
结核病药物耐药性率正在下降,其中 estreptomycin 和 isoniazid 的耐药性最高. 像rpsL,katG,rpoB和embB这样的基因中的关键突变驱动了耐药性,尽管不是唯一的.
科学领域:
- 传染病的分子流行病学.
- 抗微生物药物耐药性的机制
- 公共卫生和热带医学.
背景情况:
- 结核病 (TB) 仍然是一个全球性卫生挑战,需要持续监测耐药性模式.
- 了解耐药性的分子基础对于针对*Mycobacterium tuberculosis*复合体 (MTBC) 的有效治疗策略至关重要.
研究的目的:
- 确定MTBC分离物中对一线抗结核药物耐药性的流行率.
- 为了确定负责结核病患者耐药性的特定分子突变.
- 为开发针对性和区域特定的抗结核病治疗方案提供数据.
主要方法:
- 分析了2015-2022年间在中国洛阳市分离的3,605种MTBC菌株.
- 药物敏感性测试使用比例方法测试异化 (INH),利法 (RFP),菌素 (SM) 和乙醇 (EMB).
- 通过多色化曲线分析 (MMCA) 进行分子药物敏感性测试,以检测与耐药性相关的突变.
主要成果:
- 阻力率:SM (16.5%),INH (15.7%),RFP (9.9%),EMB (6.4%). 这三种类型的阻力比率都很高. 在城市地区观察到更高的比率.
- 在研究期间,单抗性 (MR-TB),多抗性 (MDR-TB) 和多抗性 (PDR-TB) 的下降趋势.
- 发现了关键突变: *rpsL*43 (SM), *katG*315 (INH), *rpoB*529-533 (RFP), *embB*306 (EMB). 这些突变包括: 多抗药性结核病和PRD结核病往往涉及这些热点突变的组合.
结论:
- 结核病耐药率有所下降,耐药性概况的区域差异显著.
- 特定基因的常见热点突变是药物耐药性的主要驱动因素,但其他突变也会有所贡献.
- 这些发现支持了对结核病持续监测和量身定制的治疗方法的需求.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III
312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
312
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis I
221
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
221
Sputum Studies II: Culture and Sensitivity
268
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
268
